Human Liver Models Market is expected to reach US$ 508.26 million by 2028

Liver-on-A-Chip to Lead Human Liver Models Market During 2021–2028

According to our latest study on "Human Liver Models Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Type, Application, and End User," the market is projected to reach US$ 508.26 million by 2028 from US$ 233.90 million in 2021; it is expected to grow at a CAGR of 11.7% from 2021 to 2028. The report highlights the key factors driving the market and prominent players with their developments in the market. The market's growth is primarily attributed to the increasing prevalence of liver diseases and the growing focus on developing alternatives for animal testing models. However, the high costs of human liver models and issues with incorporating liver models into existing workflow are hindering the market growth.

Based on type, the human liver models market is segmented into liver organoids, liver-on-a-chip, 2D models, 3D bioprinting, and others. The liver organoids segment is the largest shareholder in the market; however, the liver-on-a-chip segment is expected to register the highest CAGR during the forecast period.

THERMO FISHER SCIENTIFIC INC.; Emulate, Inc.; CN Bio Innovations; CYFUSE BIOMEDICAL K.K.; MIMETAS BV; InSphero; BioIVT; CELLINK; Kerafast; Cyprio; Kirkstall; and ORGANOVO HOLDINGS INC. are among leading companies operating in the human liver models market.

Human Liver Models Market, by Region, 2021 (%)

---

Human Liver Models Market Size & Share | Forecast by 2028

Download Free Sample

---

Human Liver Models Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Liver Organoids, Liver-on-a-Chip, 2D Models, 3D Bioprinting, and Others), Application (Drug Discovery, Educational, and Other), and End User (Pharmaceutical and Biotechnology Companies, Research Institutes, and Others)

The report segments the human liver models market as follows:

The human liver models market has been segmented based on type, application, and end user. Based on type, the market is segmented into liver organoids, liver-on-a-chip, 2D models, 3D bioprinting, and others. Based on application, the market is segmented into educational, drug discovery, and others. By end user, the human liver models market is segmented into research institutes, pharmaceutical and biotechnology companies, and others.

By Geography

• North America
  • US
  • Canada
  • Mexico
• Europe
  • France
  • Germany
  • UK
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific (APAC)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • Rest of APAC
• Middle East & Africa (MEA)
  • Saudi Arabia
  • UAE
  • South Africa
  • Rest of MEA
• South and Central America (SCAM)
  • Brazil
  • Argentina
  • Rest of SCAM